The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
The data driven fertility company helps increase the success rate of fertility treatments
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
The HD-550 endoscopy system has been available outside of the USA since 2019
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
Subscribe To Our Newsletter & Stay Updated
